In secondary hyperparathyroidism patients, CaSR and vitamin D receptor (VDR)-transcripts are both down-regulated in parathyroid tissue7, and the lack of CaSR expression in the parathyroid gland of some patients also leads to the progression of hyperparathyroidism and resistance to cinacalcet8,9. This evidence concerns the gene CASR and secondary hyperparathyroidism.